The new updated version of Part 7 is now available for May 2024. In this month there are three deletions to Part 7S of the drug tariff we wanted to make you aware of.

We have been advised that the May 2024 edition of Part 7 will be slightly delayed this month.

Based on evidence, there are several lines that have stabilised which you can view here with their revised price for April 2024. These are no longer treated as Adjusted Prices; however, we will continue to monitor these lines, so we ask you to please continue to use our Shortages Reporter to report any that are of concern.

Above is a roundup of the latest news affecting community pharmacy owners and their teams in Scotland.

Due to continued discussions with Public Health Scotland Part 7 of the Scottish drug tariff for April 2024 will not likely be published until early next week once all work is complete and agreed.

Please note, due to the day on which the 1st April falls this year, we will publish the April edition of Part 7 on the website slightly later than usual, early next week.

The new updated version of Part 7 is now available for March 2024. In this month there are several additions we wanted to make you aware of.

This circular sets out to community pharmacy contractors and NHS Boards the details of the community pharmacy funding arrangement 2023/24

This Circular advises of changes to the Scottish Drug Tariff effective from 1 May 2023 in respect of reimbursement of costs borne by community pharmacy contractors when dispensing NHS prescriptions for part 7 medicines.

This Circular advises of changes in the Drug Tariff effective for dispensing 1 May 2023 in respect of reimbursement of costs borne by community pharmacy contractors when dispensing NHS prescriptions for specialist preparations and imported unlicensed medicines listed in Part 7S.

Please note as of the 1st December 2021, Senna 7.5mg/5ml oral solution will be changed to Sennoside 7.5mg/5ml oral solution in Part 7b of the Scottish Drug Tariff.

There are now licensed versions of Venlafaxine Oral Suspension 37.5mg/5ml and 75mg/5ml 150ml packs available

With the Revised List of Approved List Products (PCA (P) (2021) 14) Circular, from 1st October 2021

This circular advises community pharmacy contractors and NHS Boards on the amendments to the Drug Tariff Part 7 generic clawback scale and Part 11 clawback scales.